Ir para conteúdo

Beta-Talassémia Intermédia e Minor

Cuidados Médicos

Quelação de Ferro

Iron out for nontransfused thalassemia. (abre uma nova janela)

Marks PW.

Fonte‎: Blood 2012;120(5):928-9.

Indexado‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (abre uma nova janela)

Iron overload in β-thalassemia intermedia: an emerging concern. (abre uma nova janela)

Musallam KM, Cappellini MD, Taher AT.

Fonte‎: Curr Opin Hematol 2013;20(3):187-92.

Indexado‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (abre uma nova janela)

Suplementos Alimentares e Outras Terapêuticas de Suporte

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (abre uma nova janela)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Fonte‎: Blood 2012;120(7):1531-2.

Indexado‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (abre uma nova janela)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (abre uma nova janela)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Fonte‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indexado‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (abre uma nova janela)

Therapeutic roles of curcumin: lessons learned from clinical trials. (abre uma nova janela)

Gupta SC, Patchva S, Aggarwal BB.

Fonte‎: AAPS J 2013;15(1):195-218.

Indexado‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (abre uma nova janela)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (abre uma nova janela)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Fonte‎: J Med Assoc Thai 2012;95(1):29-36.

Indexado‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (abre uma nova janela)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (abre uma nova janela)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Fonte‎: Am J Hematol 2013;88(6):503-6.

Indexado‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (abre uma nova janela)